Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Valens Company Inc (The) Ordinary Shares VLNCF

The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada... see more

OTCQX:VLNCF - Post Discussion

View:
Post by Amateur123 on Jun 07, 2022 3:09pm

Nasdaq Delisting

I know that Valens still has a few months to course correct but what countermeasures can we expect in the near term as the delisting date approaches?
Comment by mesa1 on Jun 08, 2022 12:44am
What was the cost for that Nasdaq listing? $1m USD? Brilliant.
Comment by RamboOO7 on Jun 08, 2022 3:15pm
Yes very brilliant to dish out that cash and not profitable ! All hype for big bonuses !
Comment by Capharnaum on Jun 08, 2022 12:53am
They could consolidate shares (like 5:1).
Comment by mesa1 on Jun 09, 2022 12:05pm
Another consolidation would be counter-productive given there's only 80.6m shares outstanding. Of course an equity financing to raise, say $50m to clear off debt and add working capital, at say $0.75 with a warrant (just a hypothetical example people, don't read anything into this) would increase the share issue by 67m shares to about 147m shares and of course way more fully diluted ...more  
Comment by Capharnaum on Jun 09, 2022 1:06pm
I was just answering the question. That said, considering the current market cap of $70M, a $50M share issue would represent enormous dilution. They probably should look to sell if that's the only solution.
Comment by lscfa on Jun 13, 2022 11:40am
Once a deficiency notice has been sent, the company has 90 days to comply with the continued listing standards, or 180 days if the violation was for a sub-$1.00 share price. In order to be compliant, the company's share price or market cap must rise above the minimum for at least 10 consecutive days in the 90-day (or 180-day) period.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities